Featured Products |
 |
 |
Pernix Therapeutics Holdings, Inc. is a specialty pharmaceutical company focused on the sales, marketing and development of branded and generic pharmaceutical products primarily for the pediatric market. The Company’spediatric products, designed to improve the health and well-being of children, are focused in the specific areas of allergy, upper respiratory, including nasal, chest congestion and cough, antibiotics and dermatology, including head lice, and contact dermatitis.
Recent News
- 01/23/2012 Pernix Therapeutics Announces Agreement to License a New FDA-Approved Product to Treat Gastroenterology Disease
- 12/06/2011 Pernix Therapeutics Expands Senior Management Team to Support Continued Business Growth
- 11/21/2011 Pernix Therapeutics to Present at the Piper Jaffray 23rd Annual Health Care Conference
| Founded in 1997, the Company is headquartered in The Woodlands, TX. Pernix Therapeutics Holdings, Inc. (PTX) is listed and publicly traded on the NYSE Amex. |
